Seelaus Asset Management’s Boston Scientific BSX Stock Holding History

Seelaus Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18,050	Closed	-$649K	–	220
2020 Q4	$649K	Buy	18,050 +300	+2%	+$10.8K	0.47%	69
2020 Q3	$678K	Sell	17,750 -4,300	-20%	-$166K	0.55%	55
2020 Q2	$774K	Sell	22,050 -9,650	-30%	-$348K	0.7%	46
2020 Q1	$1.03M	Sell	31,700 -4,300	-12%	-$168K	1.22%	28
2019 Q4	$1.63M	Hold	36,000	–	–	1.32%	19
2019 Q3	$1.47M	Hold	36,000	–	–	1.28%	20
2019 Q2	$1.55M	Sell	36,000 -200	-0.6%	-$7.69K	1.4%	15
2019 Q1	$1.39M	Buy	36,200 +2,950	+9%	+$113K	1.29%	19
2018 Q4	$1.18M	Hold	33,250	–	–	1.26%	26
2018 Q3	$1.28M	Hold	33,250	–	–	1.05%	29
2018 Q2	$1.09M	Sell	33,250 -200	-0.6%	-$6.03K	0.95%	39
2018 Q1	$914K	Buy	33,450 +2,500	+8%	+$67.9K	0.79%	46
2017 Q4	$767K	Buy	+30,950	New	+$854K	0.66%	57

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Seelaus Asset Management's BSX Position: Q1 2021 in Review

Seelaus Asset Management sold out of Boston Scientific (BSX) in Q1 2021, closing a stake of 18,050 shares — an estimated $649K sold.

Seelaus Asset Management first reported a position in BSX in Q4 2017 and held it in 13 quarters. The position peaked at $1.63M in Q4 2019. 830 funds tracked by Wall St. Rank hold BSX as of Q1 2021.

Seelaus Asset Management reported no remaining Boston Scientific position as of Q1 2021 after selling out during the quarter.
Seelaus Asset Management sold 18,050 Boston Scientific shares in Q1 2021, an estimated $649K.
Seelaus Asset Management first reported a position in Boston Scientific in Q4 2017 and held it in 13 quarters.
Seelaus Asset Management's Boston Scientific position peaked at $1.63M in Q4 2019.
830 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2021.

Based on Seelaus Asset Management's 13F filing for Q1 2021, filed 26 Apr 2021.